Interestingly, these pathways are downstream of the EGFR and ErbB2 family proteins whose expression and activity are related to bladder cancer progression, as well as ErbB3, FGFR3 and HRAS that are active in superficial tumors [4]. This evidence concerns the gene ERBB3 and urinary bladder carcinoma.